Global Enzyme Replacement Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024


    Table of Contents

      1 Enzyme Replacement Therapy Market Overview

      • 1.1 Product Overview and Scope of Enzyme Replacement Therapy
      • 1.2 Classification of Enzyme Replacement Therapy by Types
        • 1.2.1 Global Enzyme Replacement Therapy Revenue Comparison by Types (2019-2024)
        • 1.2.2 Global Enzyme Replacement Therapy Revenue Market Share by Types in 2018
        • 1.2.3 Injectable Agents
        • 1.2.4 Oral Agents
      • 1.3 Global Enzyme Replacement Therapy Market by Application
        • 1.3.1 Global Enzyme Replacement Therapy Market Size and Market Share Comparison by Applications (2014-2024)
        • 1.3.2 Gaucher Disease
        • 1.3.3 Fabry Disease
        • 1.3.4 MPS Disease
        • 1.3.5 Gastrointestinal Disease
        • 1.3.6 Others
      • 1.4 Global Enzyme Replacement Therapy Market by Regions
        • 1.4.1 Global Enzyme Replacement Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
        • 1.4.1 North America (USA, Canada and Mexico) Enzyme Replacement Therapy Status and Prospect (2014-2024)
        • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Enzyme Replacement Therapy Status and Prospect (2014-2024)
        • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Enzyme Replacement Therapy Status and Prospect (2014-2024)
        • 1.4.4 South America (Brazil, Argentina, Colombia) Enzyme Replacement Therapy Status and Prospect (2014-2024)
        • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Enzyme Replacement Therapy Status and Prospect (2014-2024)
      • 1.5 Global Market Size of Enzyme Replacement Therapy (2014-2024)

      2 Manufacturers Profiles

      • 2.1 Sanofi
        • 2.1.1 Business Overview
        • 2.1.2 Enzyme Replacement Therapy Type and Applications
          • 2.1.2.1 Product A
          • 2.1.2.2 Product B
        • 2.1.3 Sanofi Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.2 Shire
        • 2.2.1 Business Overview
        • 2.2.2 Enzyme Replacement Therapy Type and Applications
          • 2.2.2.1 Product A
          • 2.2.2.2 Product B
        • 2.2.3 Shire Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.3 BioMarin
        • 2.3.1 Business Overview
        • 2.3.2 Enzyme Replacement Therapy Type and Applications
          • 2.3.2.1 Product A
          • 2.3.2.2 Product B
        • 2.3.3 BioMarin Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.4 AbbVie
        • 2.4.1 Business Overview
        • 2.4.2 Enzyme Replacement Therapy Type and Applications
          • 2.4.2.1 Product A
          • 2.4.2.2 Product B
        • 2.4.3 AbbVie Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.5 Alexion
        • 2.5.1 Business Overview
        • 2.5.2 Enzyme Replacement Therapy Type and Applications
          • 2.5.2.1 Product A
          • 2.5.2.2 Product B
        • 2.5.3 Alexion Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.6 Allergan
        • 2.6.1 Business Overview
        • 2.6.2 Enzyme Replacement Therapy Type and Applications
          • 2.6.2.1 Product A
          • 2.6.2.2 Product B
        • 2.6.3 Allergan Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.7 Horizon Pharma
        • 2.7.1 Business Overview
        • 2.7.2 Enzyme Replacement Therapy Type and Applications
          • 2.7.2.1 Product A
          • 2.7.2.2 Product B
        • 2.7.3 Horizon Pharma Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.8 Johnson & Johnson
        • 2.8.1 Business Overview
        • 2.8.2 Enzyme Replacement Therapy Type and Applications
          • 2.8.2.1 Product A
          • 2.8.2.2 Product B
        • 2.8.3 Johnson & Johnson Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.9 Actelion
        • 2.9.1 Business Overview
        • 2.9.2 Enzyme Replacement Therapy Type and Applications
          • 2.9.2.1 Product A
          • 2.9.2.2 Product B
        • 2.9.3 Actelion Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.10 Recordati Rare Diseases
        • 2.10.1 Business Overview
        • 2.10.2 Enzyme Replacement Therapy Type and Applications
          • 2.10.2.1 Product A
          • 2.10.2.2 Product B
        • 2.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.11 Pfizer
        • 2.11.1 Business Overview
        • 2.11.2 Enzyme Replacement Therapy Type and Applications
          • 2.11.2.1 Product A
          • 2.11.2.2 Product B
        • 2.11.3 Pfizer Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.12 Digestive Care
        • 2.12.1 Business Overview
        • 2.12.2 Enzyme Replacement Therapy Type and Applications
          • 2.12.2.1 Product A
          • 2.12.2.2 Product B
        • 2.12.3 Digestive Care Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)
      • 2.13 Leadiant Biosciences
        • 2.13.1 Business Overview
        • 2.13.2 Enzyme Replacement Therapy Type and Applications
          • 2.13.2.1 Product A
          • 2.13.2.2 Product B
        • 2.13.3 Leadiant Biosciences Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2018)

      3 Global Enzyme Replacement Therapy Market Competition, by Players

      • 3.1 Global Enzyme Replacement Therapy Revenue and Share by Players (2014-2019)
      • 3.2 Market Concentration Rate
        • 3.2.1 Top 5 Enzyme Replacement Therapy Players Market Share
        • 3.2.2 Top 10 Enzyme Replacement Therapy Players Market Share
      • 3.3 Market Competition Trend

      4 Global Enzyme Replacement Therapy Market Size by Regions

      • 4.1 Global Enzyme Replacement Therapy Revenue and Market Share by Regions
      • 4.2 North America Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 4.3 Europe Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 4.4 Asia-Pacific Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 4.5 South America Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 4.6 Middle East and Africa Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)

      5 North America Enzyme Replacement Therapy Revenue by Countries

      • 5.1 North America Enzyme Replacement Therapy Revenue by Countries (2014-2019)
      • 5.2 USA Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 5.3 Canada Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 5.4 Mexico Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)

      6 Europe Enzyme Replacement Therapy Revenue by Countries

      • 6.1 Europe Enzyme Replacement Therapy Revenue by Countries (2014-2019)
      • 6.2 Germany Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 6.3 UK Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 6.4 France Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 6.5 Russia Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 6.6 Italy Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)

      7 Asia-Pacific Enzyme Replacement Therapy Revenue by Countries

      • 7.1 Asia-Pacific Enzyme Replacement Therapy Revenue by Countries (2014-2019)
      • 7.2 China Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 7.3 Japan Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 7.4 Korea Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 7.5 India Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 7.6 Southeast Asia Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)

      8 South America Enzyme Replacement Therapy Revenue by Countries

      • 8.1 South America Enzyme Replacement Therapy Revenue by Countries (2014-2019)
      • 8.2 Brazil Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 8.3 Argentina Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 8.4 Colombia Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)

      9 Middle East and Africa Revenue Enzyme Replacement Therapy by Countries

      • 9.1 Middle East and Africa Enzyme Replacement Therapy Revenue by Countries (2014-2019)
      • 9.2 Saudi Arabia Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 9.3 UAE Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 9.4 Egypt Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 9.5 Nigeria Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)
      • 9.6 South Africa Enzyme Replacement Therapy Revenue and Growth Rate (2014-2019)

      10 Global Enzyme Replacement Therapy Market Segment by Type

      • 10.1 Global Enzyme Replacement Therapy Revenue and Market Share by Type (2014-2019)
      • 10.2 Global Enzyme Replacement Therapy Market Forecast by Type (2019-2024)
      • 10.3 Injectable Agents Revenue Growth Rate (2014-2024)
      • 10.4 Oral Agents Revenue Growth Rate (2014-2024)

      11 Global Enzyme Replacement Therapy Market Segment by Application

      • 11.1 Global Enzyme Replacement Therapy Revenue Market Share by Application (2014-2019)
      • 11.2 Enzyme Replacement Therapy Market Forecast by Application (2019-2024)
      • 11.3 Gaucher Disease Revenue Growth (2014-2019)
      • 11.4 Fabry Disease Revenue Growth (2014-2019)
      • 11.5 MPS Disease Revenue Growth (2014-2019)
      • 11.6 Gastrointestinal Disease Revenue Growth (2014-2019)
      • 11.7 Others Revenue Growth (2014-2019)

      12 Global Enzyme Replacement Therapy Market Size Forecast (2019-2024)

      • 12.1 Global Enzyme Replacement Therapy Market Size Forecast (2019-2024)
      • 12.2 Global Enzyme Replacement Therapy Market Forecast by Regions (2019-2024)
      • 12.3 North America Enzyme Replacement Therapy Revenue Market Forecast (2019-2024)
      • 12.4 Europe Enzyme Replacement Therapy Revenue Market Forecast (2019-2024)
      • 12.5 Asia-Pacific Enzyme Replacement Therapy Revenue Market Forecast (2019-2024)
      • 12.6 South America Enzyme Replacement Therapy Revenue Market Forecast (2019-2024)
      • 12.7 Middle East and Africa Enzyme Replacement Therapy Revenue Market Forecast (2019-2024)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology

        Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.

        Scope of the Report:
        The classification of enzyme replacement therapy includes injectable agents and oral agents, and the revenue proportion of injectable agents in 2017 is about 62.38%, and the proportion is in increasing trend from 2013 to 2017.
        North America is the largest consumption place, with a consumption market share nearly 70.77% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 21.25%.
        Market competition is intense. Sanofi, Shire, BioMarin, AbbVie , etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
        The global Enzyme Replacement Therapy market is valued at 7400 million USD in 2018 and is expected to reach 15800 million USD by the end of 2024, growing at a CAGR of 13.4% between 2019 and 2024.
        The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
        North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Enzyme Replacement Therapy.
        Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
        This report studies the Enzyme Replacement Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Enzyme Replacement Therapy market by product type and applications/end industries.

        Market Segment by Companies, this report covers
        Sanofi
        Shire
        BioMarin
        AbbVie 
        Alexion
        Allergan
        Horizon Pharma
        Johnson & Johnson
        Actelion
        Recordati Rare Diseases
        Pfizer
        Digestive Care
        Leadiant Biosciences

        Market Segment by Regions, regional analysis covers
        North America (United States, Canada and Mexico)
        Europe (Germany, France, UK, Russia and Italy)
        Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        South America (Brazil, Argentina, Colombia)
        Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

        Market Segment by Type, covers
        Injectable Agents
        Oral Agents

        Market Segment by Applications, can be divided into
        Gaucher Disease
        Fabry Disease
        MPS Disease
        Gastrointestinal Disease
        Others



        Summary:
        Enzyme Replacement Therapy Market Research Report is Enzyme Replacement Therapy Market Report. Get Enzyme Replacement Therapy market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Enzyme Replacement Therapy. Enzyme Replacement Therapy Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED